Veberöd, Sweden

Eva Persson


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Eva Persson in Peritoneal Ultrafiltration

Introduction

Eva Persson is a notable inventor based in Veberöd, Sweden. She has made significant contributions to the field of medical technology, particularly in the area of peritoneal ultrafiltration. With a total of 2 patents, her work focuses on improving the treatment of patients suffering from congestive heart failure.

Latest Patents

One of her latest patents is an apparatus designed for performing peritoneal ultrafiltration. This innovative device is specifically aimed at patients who are overhydrated due to congestive heart failure. The apparatus includes a tube set with a connector for access to the peritoneal cavity of the patient. It features a flow pump that facilitates the addition and removal of fluid, ensuring effective recirculation. Additionally, an osmotic agent peristaltic pump is incorporated to replenish glucose solution, which is crucial for promoting ultrafiltration. The glucose is replenished intermittently to maintain a consistent concentration within the peritoneal cavity. The flow pump is designed with a pressure chamber and a flexible pump bag, allowing for safe management of fluid pressures during treatment.

Career Highlights

Eva Persson is associated with Triomed AB, where she continues to develop her innovative ideas. Her work has been instrumental in advancing medical devices that enhance patient care and treatment outcomes.

Collaborations

She collaborates with talented individuals such as Mikael Axelsson and Stefan Landholm, contributing to a dynamic team focused on medical advancements.

Conclusion

Eva Persson's contributions to peritoneal ultrafiltration represent a significant step forward in medical technology. Her innovative patents and collaborative efforts are paving the way for improved treatments for patients with congestive heart failure.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…